454
Participants
Start Date
December 31, 2012
Primary Completion Date
April 30, 2015
Study Completion Date
April 30, 2015
LCZ696
200 mg tablet
Olmesartan
20 mg and 40 mg capsules
LCZ696 matching placebo
LCZ696 Matching Placebo tablet
Olmesartan matching placebo
Olmesartan matching placebo capsule
amlodipine
amlodipine 2.5 mg or 5 mg tablets
hydrochlorothiazide
hydrochlorothiazide 6.25mg, 12.5mg, or 25 mg tablets
Novartis Investigative Site, Taipei
Novartis Investigative Site, Taipei
Novartis Investigative Site, Berlin
Novartis Investigative Site, Jerez de la Frontera
Novartis Investigative Site, Athens
Novartis Investigative Site, Athens
Novartis Investigative Site, Buffalo
Novartis Investigative Site, A Coruña
Novartis Investigative Site, Baltimore
Novartis Investigative Site, Treviglio
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, San Daniele del Friuli
Novartis Investigative Site, Clearwater
Novartis Investigative Site, Belzoni
Novartis Investigative Site, Jackson
Novartis Investigative Site, Taichung
Novartis Investigative Site, Seville
Novartis Investigative Site, Cincinnati
Novartis Investigative Site, Port de Sagunt
Novartis Investigative Site, Thessaloniki
Novartis Investigative Site, Pisa
Novartis Investigative Site, Chicago
Novartis Investigative Site, St Louis
Novartis Investigative Site, Paris
Novartis Investigative Site, Houston
Novartis Investigative Site, Pasadena
Novartis Investigative Site, Lake Jackson
Novartis Investigative Site, Nuremberg
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Yaroslavl
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Caba
Novartis Investigative Site, Ramos Mejía
Novartis Investigative Site, Rosario
Novartis Investigative Site, Barranquilla
Novartis Investigative Site, Barranquilla
Novartis Investigative Site, Shimotsuke
Novartis Investigative Site, Bucheon-si
Novartis Investigative Site, Seoul
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Centelles
Novartis Investigative Site, Terrassa
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY